Full history for every metric is available with a Kvantra account
Stock profile
Pharmerica Corporation (PMC)
Current price
29.25 USD+0.17%
Last close 7 Dec 2017Benchmarks
Key financial summary
Financials in USD| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 2,081 | 1,833 | 1,758 | 1,895 | 2,029 | 2,091 | 2,288 |
| Operating profit | $m | 38 | 42 | |||||
| Net profit | $m | 23 | 23 | 19 | 7 | 35 | 22 | 19 |
| EPS reported | $ | 0.69 | 0.61 | |||||
| Operating cashflow per share | $ | - | 1.00 | |||||
| Capex per share | $ | - | 1.11 | |||||
| FCF per share | $ | - | -0.11 | |||||
| Free cash flow | $m | -3 | 52 | |||||
| Net debt | $m | 468 | 452 | |||||
| Book value equity | $m | 544 | 562 | |||||
| Book value per share | $ | 17.47 | 17.91 | |||||
| Number of shares | m | 31.16 | 31.36 | |||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 1.42 | 1.65 | |||||
| P/S LTM | x | 0.37 | 0.00 | |||||
| P/FCF LTM | x | -227.06 | 0.00 | |||||
| EV/EBITDA LTM | x | 12.85 | 4.85 | |||||
| EV/Sales LTM | x | - | 0.22 | |||||
| Earnings Yield LTM | % | - | 2.41% | |||||
| FCF Yield | % | -0.44% | - | |||||
| Quality | ||||||||
| ROE | % | - | 4.06% | |||||
| ROIC | % | - | 2.53% | |||||
| Operating margin | % | - | 1.84% | |||||
| Gross margin | % | - | 15.59% | |||||
| FCF/Sales | % | - | -0.16% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | -39.47% | -45.07% | |||||
| Sales Growth YoY | % | +3.09% | +10.15% | |||||
| Net Income Growth YoY | % | -38.46% | -43.99% | |||||
| FCF Growth | % | - | +686.36% | |||||
| Operating Profit Growth | % | -28.62% | -11.39% | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | - | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | - | 0.00% | |||||
| FCF/Debt | x | -0.01 | 0.11 | |||||
| Net Debt/EBITDA | x | - | 4.85 | |||||
| EBIT/Net interest | x | - | 4.04 | |||||
| Net debt/market cap | % | 60.62% | - | |||||
| Net debt/Equity | x | 0.86 | 0.81 | |||||
| Gross debt/equity | x | 0.87 | 0.82 | |||||
Company overview
No description available.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
PM
Pharmerica Corporation (PMC)
PMC · NYSE · Healthcare
29.25 USD+0.17%
Benchmarks
Financialsin USD
20152016TTM
Total revenue $m2,0292,0912,288
Operating profit $m3842
Net profit $m352219
EPS reported $0.690.61
About
No description available.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free